NUTX Company Profile and Key Details

Q: Who are the executives of NUTX?

Ms. LaChoenda RosalesDirector of AccountingDr. Lawrence Schimmel F.A.C.S.Chief Medical Information OfficerMs. Denise PufalDirector of OperationsMs. Vivian Sanders M.B.A.Director of MarketingElizabeth HallHR Mang.Dr. Thomas T. Vo M.B.A., M.D.Chairman & Chief Executive OfficerDr. Warren Hosseinion M.D.Pres & DirectorLaTanya BrackensDirector of ComplianceMr. Michael C. BowenExecutive OfficerSarah WallaceDirector of HRJennifer Smith RodriguezInvestor Relations Mang.Ms. Pamela W. Montgomery B.S.N., J.D., L.L.M., M.S.N., R.N.Chief Legal Officer of Healthcare & Board Sec.

NASDAQ : NUTX

Nutex Health

$101.97

-23.13-18.49%

At Close 4:00 PM

61.09

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Nutex Health, Inc. (NUTX) stock declined over -18.49%, trading at $101.97 on NASDAQ, down from the previous close of $125.10. The stock opened at $123.09, fluctuating between $98.59 and $123.09 in the recent session.

Stock Snapshot

125.1

Prev. Close

607.16M

Market Cap

98.59

Day Low

6.12

P/E Ratio

16.65

EPS (TTM)

-0.01

Cash Flow per Share

123.09

Open

5.95M

Number of Shares

123.09

Day High

59.46%

Free Float in %

0.09

Book Value

507.08K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Feb 05, 2026	123.09	123.09	98.59	101.97	506.32K
Feb 04, 2026	152.23	152.23	123.33	125.10	408.18K
Feb 03, 2026	161.64	165.00	152.56	154.47	368.26K
Feb 02, 2026	150.00	161.75	149.00	161.25	210.81K
Jan 30, 2026	148.62	155.20	148.00	148.79	162.16K
Jan 29, 2026	150.31	151.00	145.00	148.53	127.92K
Jan 28, 2026	156.77	156.77	149.17	149.80	83.56K
Jan 27, 2026	159.84	162.13	149.98	153.81	134.56K
Jan 26, 2026	157.26	160.05	153.80	159.74	133.07K
Jan 23, 2026	157.02	163.13	155.78	156.21	141.92K
Jan 22, 2026	147.98	170.00	147.98	159.42	243.61K
Jan 21, 2026	154.14	154.14	141.06	146.97	183.5K
Jan 20, 2026	149.89	158.11	148.00	153.76	177.25K
Jan 16, 2026	164.08	170.00	149.00	152.77	260.53K
Jan 15, 2026	169.74	172.10	160.00	164.21	141.52K
Jan 14, 2026	172.34	179.94	164.00	165.90	173.83K
Jan 13, 2026	183.04	184.03	165.24	172.60	154.18K
Jan 12, 2026	185.00	189.45	175.25	180.72	124.19K
Jan 09, 2026	184.11	192.00	183.00	186.18	137.63K
Jan 08, 2026	178.85	186.50	178.09	184.11	139.6K

Contact Details

Houston, TX 77081

United States

https://www.nutexhealth.com 713 660 0557

About Company

Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.

Stock Peers

BTSGU

2.35+1.86%

BrightSpring Health Services, Inc. Tangible Equity Unit$128.48 WGS

-1.27-1.49%

GeneDx Holdings Corp.$84.08 GEHC

-0.32-0.39%

GE HealthCare Technologies Inc.$82.31 HQY

-2.12-2.61%

HealthEquity, Inc.$79.22 TEM

-1.11-2.07%

Tempus AI, Inc.$52.44 OMCL

-7.61-16.30%

Omnicell, Inc.$39.08 BTSG

1.08+2.90%

BrightSpring Health Services, Inc. Common Stock$38.36 PINC

0.09+0.32%

Premier, Inc.$28.26 HTFL

-2.15-7.64%

Heartflow, Inc. Common Stock$25.99 CCLDO

-0.1999-0.77%

CareCloud, Inc.$25.80

Company Overview

Nutex Health, Inc. (NASDAQ:NUTX) closed at $101.97 USD, losing -$23.13 (-18.49%) from the previous close of $125.10. The stock is currently mid-range between its 52-week high and low $40.67 and $193.07. With a market capitalization of about $607.16 million, Nutex Health, Inc. is classified as a small-cap and shows higher-than-market volatility (beta ~1.94). Key stats such as the average daily volume over the past year has been around 185.88 thousand shares, trading with heavier-than-usual volume. Headquartered in Houston, TX, Nutex Health, Inc. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Thomas T. Vo, the company employs approximately 800 people and listed since April 04, 2022. Nutex Health, Inc. operates as a technology-enabled healthcare services company.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -34.77%, SMA50 -35.82%, SMA200 -18.64%). The stock’s 14-day RSI is 28.74 (weak momentum), while the ATR of 14.81 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -47.18% below its high and over 150.73% above its low. Average 10-day trading volume of 250.22 thousand shares is slightly above the 3-month average of 187.70 thousand, indicating heightened recent market interest.

Valuation Metrics

Nutex Health, Inc. trades at a P/E ratio of 5.83, slightly below the S&P 500 average, with a price-to-sales ratio of 0.6 and a price-to-book ratio of 2.1 suggesting the stock is closer to book value. The P/FCF stands at 2.64, also above market averages.

Dividend & Fair Value

Nutex Health, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $320.62. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Wall Street analysts project EPS growth of 38.76% annually over the next five years. The latest quarter delivered EPS of $7.76. The next quarter is forecast at $5.56. Next year's EPS is expected at $40.00. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $225.00 to $75.00. The high target offers 120.65% upside. The low target suggests -26.45% downside. The mean target is $151.25. This offers 48.33% upside. Nutex Health, Inc. earnings surprise history is a mixed track record. The quarter that ended November 19, 2025, missed forecasts by 80.89%. The prior quarter beat by -251.28%. Over the last six quarters, Apple has recorded several small beats. These include -12455.56% in March 31, 2025.

Shareholding & Insider Activity

Nutex Health, Inc. has 5.56 million shares outstanding. The public float is 3.30 million shares, elevated short interest at 24.89% of float. This equals 892.07 thousand shares. The short ratio is 3.14 days. Institutional investors hold 49.89% of the float. Insiders own 35.81%. Premier Macy Management Holdings, LLC holds 41.96 million shares, Vo Thomas T. has 18.06 million shares and Dogan Meeshanthini has 1.66 million shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Financial & Profitability Overview

Over the trailing twelve months, Nutex Health generated $247.65M in revenue, or $0.37 per share. Gross margin was 14.04%, operating margin -0.52%, and net profit margin -18.49%. Returns are negative, with ROA at -11.50% and ROE at -74.51%.
On valuation metrics, Nutex Health trades at a P/E of 5.83, P/S of 0.60 and P/B of 2.10. The current ratio is 3.20 and quick ratio is 3.18. Operationally, the company’s inventory turnover is 139.78 and cash conversion cycle is 105.75 days. Debt-to-equity is 1.13, supported by a cash flow-to-debt ratio of 0.63.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Nutex Health posted revenue of $247.65M, down slightly from $219.29M in the prior quarter. Gross profit was $34.77M (margin 14.04%). Operating income was - $1.29M (margin -0.5%). Net income was- $45.79M (EPS - $0.07).
The company ended the quarter with $22.00M in cash and short-term investments, a total debt of $275.76M, and net debt of $253.75M. Total assets were $398.25M, with equity of $79.11M. Financials further reflected stability, with operating cash flow of $1.26M, free cash flow of - $8.24M, and capital expenditures of - $9.50M.

Price Forecast & Outlook

Our AI price prediction model suggests that Nutex Health, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.14%, with price expected at $104.15 by February 19, 2026, within a range of $93.81 to $114.62 3-Month Outlook: Projected rise of 114.65%, reaching $218.88 by May 05, 2026, with a range of $216.15 to $221.96. 1-Year Outlook: Projected gain of 12.53%, with price at $114.75 by February 05, 2027, within a range of $87.26 to $139.07.

Key Takeaways

Nutex Health, Inc. (NASDAQ:NUTX) shares are flat -6.6% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Nutex Health, Inc. trading at a premium to the broader market with a P/E of 5.83. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $64.45, suggesting -36.8% downside. Our AI forecast model points to short-term strength (2.14% over two weeks), a medium-term rise (114.65% over three months), and a longer-term gain (12.53% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Nutex Health, Inc. (NUTX) stock price?

Nutex Health, Inc. (NASDAQ: NUTX) stock price is $101.97 in the last trading session. During the trading session, NUTX stock reached the peak price of $123.09 while $98.59 was the lowest point it dropped to. The percentage change in NUTX stock occurred in the recent session was -18.49% while the dollar amount for the price change in NUTX stock was - $23.13.

NUTX's industry and sector of operation?

The NASDAQ listed NUTX is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector. Nutex Health, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NUTX?

Ms. LaChoenda Rosales
Director of Accounting
Dr. Lawrence Schimmel F.A.C.S.
Chief Medical Information Officer
Ms. Denise Pufal
Director of Operations
Ms. Vivian Sanders M.B.A.
Director of Marketing
Elizabeth Hall
HR Mang.
Dr. Thomas T. Vo M.B.A., M.D.
Chairman & Chief Executive Officer
Dr. Warren Hosseinion M.D.
Pres & Director
LaTanya Brackens
Director of Compliance
Mr. Michael C. Bowen
Executive Officer
Sarah Wallace
Director of HR
Jennifer Smith Rodriguez
Investor Relations Mang.
Ms. Pamela W. Montgomery B.S.N., J.D., L.L.M., M.S.N., R.N.
Chief Legal Officer of Healthcare & Board Sec.

How NUTX did perform over past 52-week?

NUTX's closing price is 150.72% higher than its 52-week low of $40.67 where as its distance from 52-week high of $193.07 is -47.19%.

How many employees does NUTX have?

Number of NUTX employees currently stands at 800.

Link for NUTX official website?

Official Website of NUTX is: https://www.nutexhealth.com

How do I contact NUTX?

NUTX could be contacted at phone 713 660 0557 and can also be accessed through its website. NUTX operates from 6030 South Rice Avenue, Houston, TX 77081, United States.

How many shares of NUTX are traded daily?

NUTX stock volume for the day was 507.08K shares. The average number of NUTX shares traded daily for last 3 months was 185.88K.

What is the market cap of NUTX currently?

The market value of NUTX currently stands at $607.16M with its latest stock price at $101.97 and 5.95M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	800
Beta	1.94
Sales or Revenue	$247.65M
5Y Sales Change%	4,415.92%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Healthcare Information Services

NUTX Company Profile and Key Details

Nutex Health

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Valuation Metrics

Shareholding & Insider Activity

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Key Takeaways

Price Forecast & Outlook